AbbVie's strategic move into the obesity market through a partnership with Gubra A/S shows potential but won't impact revenue ...

ADCs are currently at the forefront of cancer treatment, but persistent drug development challenges call for a new approach.

Results Have Been Submitted Ahead of In-Person Meeting with FDA Set for April 2CTx-1301 is the First, True, Once-Daily Stimulant Medication to ...

Equities research analysts at Brookline Capital Management issued their Q2 2025 EPS estimates for shares of C4 Therapeutics ...

MINNEAPOLIS/ST. PAUL (3/04/2025) — Making decisions in uncertain situations is part of daily life. New research from the University of Minnesota Medical School has uncovered that anxiety and apathy — ...

Paramagnetic rim lesions help confirm multiple sclerosis diagnoses and may have prognostic value. New evidence of an immune ...

Wedbush reaffirmed their outperform rating on shares of Y-mAbs Therapeutics (NASDAQ:YMAB – Free Report) in a research note ...

A high-fish diet is linked to less MS disability progression over time, which could be explained by high levels of omega 3 ...

Background Effective management of coexisting heart failure (HF), chronic kidney disease (CKD) and type 2 diabetes mellitus ...

Q4 2024 Earnings Call Transcript March 3, 2025 Fortrea Holdings Inc. misses on earnings expectations. Reported EPS is $0.18 ...

Across six asthma biologics, adherence differed by the therapy given and was often low or irregular based on three adherence measures, according to a presentation here.This cross-sectional cohort ...

The authors have demonstrated the use of adenine base editors delivered via adeno-associated viruses to introduce edits in the mitochondrial genome. The manuscript describes the methodology well, and ...